SignatureFD’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.88K | Sell |
535
-284
| -35% | -$2.59K | ﹤0.01% | 2603 |
|
|
2025
Q1 | $6.51K | Buy |
819
+109
| +15% | +$867 | ﹤0.01% | 2495 |
|
|
2024
Q4 | $3.86K | Buy |
710
+199
| +39% | +$1.08K | ﹤0.01% | 2675 |
|
|
2024
Q3 | $3.69K | Buy |
511
+65
| +15% | +$469 | ﹤0.01% | 2650 |
|
|
2024
Q2 | $4.84K | Buy |
446
+101
| +29% | +$1.1K | ﹤0.01% | 2522 |
|
|
2024
Q1 | $6.47K | Sell |
345
-191
| -36% | -$3.58K | ﹤0.01% | 2457 |
|
|
2023
Q4 | $11.6K | Buy |
536
+357
| +199% | +$7.74K | ﹤0.01% | 2190 |
|
|
2023
Q3 | $3.68K | Sell |
179
-122
| -41% | -$2.51K | ﹤0.01% | 2589 |
|
|
2023
Q2 | $14.2K | Sell |
301
-86
| -22% | -$4.04K | ﹤0.01% | 2063 |
|
|
2023
Q1 | $16.2K | Buy |
387
+66
| +21% | +$2.77K | ﹤0.01% | 1986 |
|
|
2022
Q4 | $12.2K | Sell |
321
-105
| -25% | -$4.01K | ﹤0.01% | 2049 |
|
|
2022
Q3 | $17K | Buy |
426
+95
| +29% | +$3.79K | ﹤0.01% | 1830 |
|
|
2022
Q2 | $11K | Buy |
+331
| New | +$11K | ﹤0.01% | 2078 |
|
|
2022
Q1 | – | Sell |
-14
| Closed | -$1K | – | 3296 |
|
|
2021
Q4 | $1K | Sell |
14
-13
| -48% | -$929 | ﹤0.01% | 2983 |
|
|
2021
Q3 | $1K | Sell |
27
-57
| -68% | -$2.11K | ﹤0.01% | 2906 |
|
|
2021
Q2 | $5K | Sell |
84
-8
| -9% | -$476 | ﹤0.01% | 2291 |
|
|
2021
Q1 | $7K | Hold |
92
| – | – | ﹤0.01% | 2020 |
|
|
2020
Q4 | $8K | Sell |
92
-184
| -67% | -$16K | ﹤0.01% | 1793 |
|
|
2020
Q3 | $17K | Buy |
276
+76
| +38% | +$4.68K | ﹤0.01% | 1443 |
|
|
2020
Q2 | $8K | Hold |
200
| – | – | ﹤0.01% | 1645 |
|
|
2020
Q1 | $6K | Buy |
+200
| New | +$6K | ﹤0.01% | 1638 |
|